Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. (KTTA) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · KTTA · as of Jun 9, 2026
Activity summary
Buy transactions
2
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Pasithea Therapeutics Corp. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
KTTA insider buying and selling by quarter
KTTA insider selling · KTTA insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · KTTA ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
KTTA executive sell shares · KTTA board member insider trading · KTTA insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 28, 2025 | STEINMAN LAWRENCE Director | Purchase | 133,333 | $100K | Form 4 |
| Nov 28, 2025 | Schneiderman Daniel H CFO | Award | 26,667 | $20K | Form 4 |
| Nov 28, 2025 | Marques Tiago CEO · Director | Purchase | 33,333 | $25K | Form 4 |
| Nov 28, 2025 | Dumesnil Simon Director | Purchase | 33,333 | $25K | Form 4 |
| Nov 28, 2025 | Leahy Emer Director | Award | 33,333 | $25K | Form 4 |
| May 12, 2025 | Marques Tiago CEO · Director | Sale | 960 | $792 | Form 4 |
| Jun 13, 2024 | Novak Alfred J Director | Award | 2,750 | $15K | Form 4 |
| Jun 12, 2024 | Novak Alfred J Director | Award | 750 | $4K | Form 4 |
| Jun 2, 2023 | STEINMAN LAWRENCE Director | Purchase | 30,000 | $13K | Form 4 |
| Nov 28, 2022 | STEINMAN LAWRENCE Director | Award | 5,000 | $5K | Form 4 |
| Nov 25, 2022 | Marques Tiago CEO | Award | 2,000 | $2K | Form 4 |
| Nov 23, 2022 | Marques Tiago CEO | Award | 1,206 | $1K | Form 4 |
| Nov 23, 2022 | Marques Tiago CEO | Award | 1,000 | $1K | Form 4 |
| Nov 23, 2022 | Marques Tiago CEO | Award | 5,000 | $5K | Form 4 |
| Nov 22, 2022 | STEINMAN LAWRENCE Director | Award | 5,000 | $5K | Form 4 |
| Nov 17, 2022 | Dumesnil Simon Director | Award | 40,000 | $42K | Form 4 |
| Nov 15, 2022 | Dumesnil Simon Director | Award | 10,000 | $11K | Form 4 |
| Oct 26, 2022 | STEINMAN LAWRENCE Director | Award | 5,000 | $6K | Form 4 |
| Oct 21, 2022 | Marques Tiago CEO | Award | 4,400 | $5K | Form 4 |
| Oct 21, 2022 | Marques Tiago CEO | Award | 600 | $648 | Form 4 |
| Oct 17, 2022 | Delaney David Director | Purchase | 1,000 | $1K | Form 4 |
| Oct 17, 2022 | STEINMAN LAWRENCE Director | Award | 9,000 | $10K | Form 4 |
| Oct 17, 2022 | STEINMAN LAWRENCE Director | Award | 1,000 | $1K | Form 4 |
| Sep 28, 2022 | Camac Partners, LLC Director | Purchase | 6,710 | $8K | Form 4 |
| Sep 29, 2022 | Shahinian Eric 10% Owner | Purchase | 6,710 | $8K | Form 4 |
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About KTTA insider trading
KTTA insider trades
Pasithea Therapeutics Corp. (KTTA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including STEINMAN LAWRENCE (Director), Schneiderman Daniel H (CFO), Marques Tiago (CEO · Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. KTTA insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Pasithea Therapeutics Corp.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
KTTA insider trading · 5 questionsThe insiders of Pasithea Therapeutics Corp. (KTTA) include executives and directors such as STEINMAN LAWRENCE (Director), Schneiderman Daniel H (CFO), Marques Tiago (CEO · Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026